| Datum | Zeit | Quelle | Überschrift | Symbol | Firma |
| 02/11/2012 | 11h03 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:OPNT | Opiant Pharmaceuticals Inc |
| 01/11/2012 | 23h27 | PR Newswire (US) | Barrett Johnston, LLC Announces Investigation Of OPNET Technologies, Inc. | NASDAQ:OPNT | Opiant Pharmaceuticals Inc |
| 01/11/2012 | 21h48 | Edgar (US Regulatory) | Amended Annual Report (10-k/a) | NASDAQ:OPNT | Opiant Pharmaceuticals Inc |
| 01/11/2012 | 21h48 | Edgar (US Regulatory) | Amended Annual Report (10-k/a) | NASDAQ:OPNT | Opiant Pharmaceuticals Inc |
| 01/11/2012 | 21h48 | Edgar (US Regulatory) | Amended Annual Report (10-K/A) | NASDAQ:OPNT | Opiant Pharmaceuticals Inc |
| 01/11/2012 | 21h48 | Edgar (US Regulatory) | Amended Annual Report (10-k/a) | NASDAQ:OPNT | Opiant Pharmaceuticals Inc |
| 01/11/2012 | 21h48 | Edgar (US Regulatory) | Amended Annual Report (10-k/a) | NASDAQ:OPNT | Opiant Pharmaceuticals Inc |
| 01/11/2012 | 21h48 | Edgar (US Regulatory) | Amended Annual Report (10-k/a) | NASDAQ:OPNT | Opiant Pharmaceuticals Inc |
| 01/11/2012 | 18h43 | PR Newswire (US) | SHAREHOLDER ALERT: Law Firm of Levi & Korsinsky, LLP Announces Investigation of The Warnaco Group, Inc. (WRC), OPNET Technolo... | NASDAQ:OPNT | Opiant Pharmaceuticals Inc |
| 01/11/2012 | 15h15 | PR Newswire (US) | OPNET Technologies, Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By Riverbed Technol... | NASDAQ:OPNT | Opiant Pharmaceuticals Inc |
| 01/11/2012 | 11h04 | Edgar (US Regulatory) | Filing of certain prospectuses and communications in connection with business combination transactions (425) | NASDAQ:OPNT | Opiant Pharmaceuticals Inc |
| 01/11/2012 | 11h04 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:OPNT | Opiant Pharmaceuticals Inc |
| 01/11/2012 | 11h04 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:OPNT | Opiant Pharmaceuticals Inc |
| 01/11/2012 | 11h04 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:OPNT | Opiant Pharmaceuticals Inc |
| 01/11/2012 | 11h04 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:OPNT | Opiant Pharmaceuticals Inc |
| 01/11/2012 | 11h04 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:OPNT | Opiant Pharmaceuticals Inc |
| 01/11/2012 | 11h04 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:OPNT | Opiant Pharmaceuticals Inc |
| 01/11/2012 | 11h04 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:OPNT | Opiant Pharmaceuticals Inc |
| 01/11/2012 | 02h30 | PR Newswire (US) | Law Office of Brodsky & Smith, LLC Announces Investigation of OPNET Technologies, Inc. | NASDAQ:OPNT | Opiant Pharmaceuticals Inc |
| 31/10/2012 | 21h02 | Edgar (US Regulatory) | Mutual Fund Summary Prospectus (497k) | NASDAQ:OPNT | Opiant Pharmaceuticals Inc |
| 31/10/2012 | 21h02 | Edgar (US Regulatory) | Mutual Fund Summary Prospectus (497k) | NASDAQ:OPNT | Opiant Pharmaceuticals Inc |
| 31/10/2012 | 21h01 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:OPNT | Opiant Pharmaceuticals Inc |
| 31/10/2012 | 21h01 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:OPNT | Opiant Pharmaceuticals Inc |
| 31/10/2012 | 21h01 | Edgar (US Regulatory) | Mutual Fund Summary Prospectus (497k) | NASDAQ:OPNT | Opiant Pharmaceuticals Inc |
| 31/10/2012 | 21h01 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:OPNT | Opiant Pharmaceuticals Inc |
| 31/10/2012 | 21h01 | Edgar (US Regulatory) | Mutual Fund Summary Prospectus (497k) | NASDAQ:OPNT | Opiant Pharmaceuticals Inc |
| 31/10/2012 | 21h01 | Edgar (US Regulatory) | Mutual Fund Summary Prospectus (497k) | NASDAQ:OPNT | Opiant Pharmaceuticals Inc |
| 31/10/2012 | 21h01 | Edgar (US Regulatory) | Filing of certain prospectuses and communications in connection with business combination transactions (425) | NASDAQ:OPNT | Opiant Pharmaceuticals Inc |
| 31/10/2012 | 17h01 | Business Wire | Ryan & Maniskas, LLP Announces Investigation of OPNET Technologies, Inc. | NASDAQ:OPNT | Opiant Pharmaceuticals Inc |
| 30/10/2012 | 22h27 | PR Newswire (US) | SHAREHOLDER ALERT: Law Firm of Levi & Korsinsky, LLP Announces Investigation of OPNET Technologies Inc. (OPNT), PSS World Med... | NASDAQ:OPNT | Opiant Pharmaceuticals Inc |